Having enough cash on hand during market sell-offs can allow investors to purchase both value and growth stocks at a bargain price. Here are two companies to consider.
News & Analysis: Bausch Health Companies
Bausch's decision to carve out its eye care business into a stand-alone unit appears to be a hit with investors.
The stock rebounded on Friday in lockstep with the broader biopharmaceutical industry.
Bausch's shares are being pulled under by the marketwide sell-off today.
Hint: It's what caused nearly every stock to sink.
A late-year growth upgrade sent shares higher to close out 2019.
Bausch's better-than-expected third-quarter numbers delighted investors last month.
A lawsuit over the company's top-selling drug caused investors to worry.
It was one of the best-performing healthcare stocks last month. Two new product launches and a big debt repayment were the primary contributors.
Bausch's comeback hit a minor stumbling block last month. Here's why.
Investors applauded news of the end of a patent fight.